Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tenax Therapeutics, Inc.

NASDAQ: TENX · Life Sciences · 3 alerts · CIK 34956

Share price
$1.48Close, Nov 16
Market cap
$67.4M
Shares outstanding
45.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tenax Therapeutics, Inc. filings on SEC EDGAR ↗

4:11 PM ET 10-Q
Financial Results

Tenax Therapeutics Q3 2026 Results: Net Loss of $16.7M, Loss Widens

Tenax Therapeutics reported a net loss of $50.2 million for the nine months ended September 30, 2026, driven by increased research and development costs for its cardiopulmonary therapies. Despite the loss, the company strengthened its liquidity position to $113.7 million in cash and cash equivalents, primarily through $52.1 million in proceeds from the exercise of warrants and options. Management believes current funds are sufficient to support operations for at least the next 12 months.

Key figure
Net loss $16.7M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.